abstract |
The present invention relates to a method of treating a disease, disorder or condition in a patient, comprising administering to the patient a therapeutically effective amount of a thiazole derivative, tetomilast. The invention also relates to administering one or more beta 2 -adrenergic receptor agonists in combination with tetomillast to treat a disease, disorder or condition. The invention also relates to administering anti-inflammatory steroids in combination with tetomillast and one or more beta 2 -adrenergic receptor agonists to treat a disease, disorder or condition. |